Abstract
Immunohistochemical studies of the presence of lactosylceramide (LacCer) in lysosomal storage disorders (LSDs) were done using anti-LacCer monoclonal antibody of the CDw17 type (clone MG-2). No sign of an association between LacCer and the lysosomal system in normal cells was observed, except for histiocytes active in phagocytosis. A comparative study of a group of LSDs showed a general tendency for LacCer to increase in storage cells in Niemann-Pick disease type C (NPC), and types A and B, GM1 gangliosidosis, acid lipase deficiency, glycogen storage disease type II and mucopolysaccharidoses. LacCer accumulated in storage cells despite normal activity of relevant lysosomal degrading enzymes. The accumulation of LacCer displayed variability within storage cell populations, and was mostly expressed in neurons in NPC. An absence of the increase in LacCer in storage cells above control levels was seen in neuronal ceroid lipofuscinoses (neurons and cardiocytes) and in Fabry disease. Gaucher and Krabbe cells showed significantly lower levels, or even the absence, of LacCer compared with control macrophages. Results of immunohistochemistry were corroborated by semiquantitative lipid thin-layer chromatography (TLC). It is suggested that different associations of LacCer with the lysosomal storage process may reflect differences in glycosphingolipid turnover induced by the storage-compromised lysosomal/endosomal system.
Similar content being viewed by others
References
Abe T, Okada R (1972) Lipid analysis of a case of GM1-generalized gangliosidosis. Jpn J Exp Med 42:543–551
Angstrom J, Teneberg S, Milh MA, Larsson T, Leonardsson I, Olsson BM, Halvarsson MO, Danielsson D, Naslund I, Ljungh A, Wadstrom T, Karlsson KA (1998) The lactosylceramide binding specificity of Helicobacter pylori. Glycobiology 8:297–309
Arai T, Bhunia AK, Chatterjee S, Bulkley GB (1998) Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in vitro. Circ Res 82:540–547
Bhunia AK, Han H, Snowden A, Chatterjee S (1996) Lactosylceramide stimulates Ras-GTP loading, kinases (MEK, Raf), p44 mitogen-activated protein kinase, and c-fos expression in human aortic smooth muscle cells. J Biol Chem 271:10660–10666
Bhunia AK, Arai T, Bulkley G, Chatterjee S (1998) Lactosylceramide mediates tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 (ICAM-1) expression and the adhesion of neutrophil in human umbilical vein endothelial cells. J Biol Chem 273:34349–34357
Bradova V, Smid F, Ulrich-Bott B, Roggendorf W, Paton BC, Harzer K (1993) Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease. Hum Genet 92:143–152
Brady RO, King FM (1973) Gaucher’s disease. In: Hers HG, Van Hoof F (ed) Lysosomes and storage diseases. Academic Press, New York, pp 381–394
Brady RO, O’Brien JS, Bradley RM, Gal AE (1970) Sphingolipid hydrolases in brain tissue of patients with generalized gangliodosis. Biochim Biophys Acta 210:193–195
Brooks SA, Dwek MV, Shumacher U (eds) (2002) Functional and molecular glycobiology. BIOS Scientific Publishers, Oxford
Brown DA, Rose JK (1992) Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68:533–544
Brunngraber EG, Berra B, Zambotti V (1973) Altered levels of tissue glycoproteins, gangliosides, glycosaminoglycans and lipids in Niemann-Pick’s disease. Clin Chim Acta 48:173–181
Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J, Polymeropoulos MH, Sturley SL, Ioannou YA, Higgins ME, Comly M, Cooney A, Brown A, Kaneski CR, Blanchette-Mackie EJ, Dwyer NK, Neufeld EB, Chang TY, Liscum L, Tagle DA, et al (1997) Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277:228–231
Constantopoulos G, Shull RM, Hastings N, Neufeld EF (1985) Neurochemical characterization of canine alpha-L-iduronidase deficiency disease (model of human mucopolysaccharidosis I). J Neurochem 45:1213–1217
Cox TM (2001) Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses. J Inherit Metab Dis 24 [Suppl 2]:106–121 (discussion 87–88)
Dawson G, Oh JY (1977) Blood glucosylceramide levels in Gaucher’s disease and its distribution amongst lipoprotein fractions. Clin Chim Acta 75:149–153
Ebato H, Abe T, Yamakawa T, Nagashima K (1980) Characterization of the cytoplasmic inclusion bodies of the spleens from patients with adult form Gaucher’s disease. J Biochem (Tokyo) 88:1765–1772
Elleder M (1978) A histochemical and ultrastructural study of stored material in neuronal ceroid lipofuscinosis. Virchows Arch B Cell Pathol 28:167–178
Elleder M, Jirasek A (1981) Histochemical and ultrastructural study of Gaucher cells. Acta Neuropathol Suppl (Berl) 7:208–210
Elleder M, Lojda Z (1971) Studies in lipid histochemistry. VI. Problems of extraction with acetone in lipid histochemistry. Histochemie 28:68–87
Elleder M, Jirasek A, Smid F, Ledvinova J, Besley GT (1985) Niemann-Pick disease type C. Study on the nature of the cerebral storage process. Acta Neuropathol (Berl) 66:325–336
Elleder M, Dorazilova V, Bradova V, Belohlavek M, Kral V, Choura M, Budesinsky M, Harzer K (1990) Fabry’s disease with isolated disease of the cardiac muscle, manifesting as hypertrophic cardiomyopathy. Cas Lek Cesk 129:369–372
Elleder M, Chlumska A, Hyanek J, Poupetova H, Ledvinova J, Maas S, Lohse P (2000) Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer. J Hepatol 32:528–534
Goyert SM (1996) CDw17 workshop panel report. In: Kishimoto T (ed) Leucocyte typing VI, Kobe, Japan. Garland Publishing, New York, pp 971–972
Greenbaum M, Hoffman LM, Schneck L (1976) Ceramide hexosides in Niemann-Pick disease brain. J Neurol 213:251–255
Hadfield MG, Ghatak NR, Nakoneczna I, Lippman HR, Myer EC, Constantopoulos G, Bradley RM (1980) Pathologic findings in mucopolysaccharidosis type IIIB (Sanfilippo’s syndrome B). Arch Neurol 37:645–650
Hara A, Kitazawa N, Taketomi T (1984) Abnormalities of glycosphingolipids in mucopolysaccharidosis type III B. J Lipid Res 25:175–184
Harzer K, Paton BC, Poulos A, Kustermann-Kuhn B, Roggendorf W, Grisar T, Popp M (1989) Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses. Eur J Pediatr 149:31–39
Hers HG, de Barsy T (1973) Type II glycogenosis (acid maltase deficiency). In: Hers HG, Van Hoof F (ed) Lysosomes and storage diseases. Academic Press, New York, pp 197–217
Hulkova H, Ledvinova J, Poupetova H, Bultas J, Zeman J, Elleder M (1999) Postmortem diagnosis of Fabry disease in a female heterozygote leading to the detection of undiagnosed manifest disease in the family. Cas Lek Cesk 138:660–664
Hulkova H, Cervenkova M, Ledvinova J, Tochackova M, Hrebicek M, Poupetova H, Befekadu A, Berna L, Paton BC, Harzer K, Boor A, Smid F, Elleder M (2001) A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum Mol Genet 10:927–940
Chatterjee S (1998) Sphingolipids in atherosclerosis and vascular biology. Arterioscler Thromb Vasc Biol 18:1523–1533
Chatterjee S, Sekerke CS, Kwiterovich PO Jr (1982) Increased urinary excretion of glycosphingolipids in familial hypercholesterolemia. J Lipid Res 23:513–522
Chatterjee S, Kwiterovich PO Jr, Gupta P, Erozan YS, Alving CR, Richards RL (1983) Localization of urinary lactosylceramide in cytoplasmic vesicles of renal tubular cells in homozygous familial hypercholesterolemia. Proc Natl Acad Sci U S A 80:1313–1317
Chatterjee S, Dey S, Shi WY, Thomas K, Hutchins GM (1997) Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues. Glycobiology 7:57–65
Chen CS, Patterson MC, Wheatley CL, O’Brien JF, Pagano RE (1999) Broad screening test for sphingolipid-storage diseases. Lancet 354:901–905
Iwabuchi K, Nagaoka I (2002) Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils. Blood 100:1454–1464
Iwamoto T, Fukumoto S, Kanaoka K, Sakai E, Shibata M, Fukumoto E, Inokuchi Ji J, Takamiya K, Furukawa K, Kato Y, Mizuno A (2001) Lactosylceramide is essential for the osteoclastogenesis mediated by macrophage-colony-stimulating factor and receptor activator of nuclear factor-kappa B ligand. J Biol Chem 276:46031–46038
Kahma K, Brotherus J, Haltia M, Renkonen O (1976) Low and moderate concentrations of lysobisphosphatidic acid in brain and liver of patients affected by some storage diseases. Lipids 11:539–544
Kamoshita S, Aron AM, Suzuki K (1969) Infantile Niemann-Pick disease. A chemical study with isolation and characterization of membranous cytoplasmic bodies and myelin. Am J Dis Child 117:379–394
Kannan R, Tjiong HB, Debuch H, Wiedemann HR (1974) Unusual glycolipids in brain cortex of a visceral lipidosis (Niemann-Pick disease?). Hoppe Seylers Z Physiol Chem 355:551–556
Kasama T, Taketomi T (1986) Abnormalities of cerebral lipids in GM1-gangliosidoses, infantile, juvenile, and chronic type. Jpn J Exp Med 56:1–11
Klibansky C, Ossimi Z, Matoth Y, Pinkhas J, de Vries A (1976) Accumulation of lactosyl ceramide in leukocytes of patients with adult Gaucher’s disease. Clin Chim Acta 72:141–146
Kojima N, Shiota M, Sadahira Y, Handa K, Hakomori S (1992) Cell adhesion in a dynamic flow system as compared to static system. Glycosphingolipid-glycosphingolipid interaction in the dynamic system predominates over lectin- or integrin-based mechanisms in adhesion of B16 melanoma cells to non-activated endothelial cells. J Biol Chem 267:17264–17270
Koubek K, Korinkova P, Hruba A, Hausner P (1988) Human leukocyte markers defined by monoclonal antibodies. I. Expression of X-hapten structure on cells of myeloid lineage. Folia Haematol Int Mag Klin Morphol Blutforsch 115:913–926
Kuske TT, Rosenberg A (1972) Quantity and fatty acyl composition of the glycosphingolipids of Gaucher spleen. J Lab Clin Med 80:523–529
Ledeen RW, Yu RK, Eng LF (1973) Gangliosides of human myelin: sialosylgalactosylceramide (G7) as a major component. J Neurochem 21:829–839
Lingwood CA (1998) Oligosaccharide receptors for bacteria: a view to a kill. Curr Opin Chem Biol 2:695–700
Lund-Johansen F, Olweus J, Horejsi V, Skubitz KM, Thompson JS, Vilella R, Symington FW (1992) Activation of human phagocytes through carbohydrate antigens (CD15, sialyl-CD15, CDw17, and CDw65). J Immunol 148:3221–3229
Lusa S, Blom TS, Eskelinen EL, Kuismanen E, Mansson JE, Simons K, Ikonen E (2001) Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane. J Cell Sci 114:1893–1900
Malinina L, Malakhova ML, Teplov A, Brown RE, Patel DJ (2004) Structural basis for glycosphingolipid transfer specificity. Nature 430:1048–1053
Matsuo H, Chevallier J, Mayran N, Le Blanc I, Ferguson C, Faure J, Blanc NS, Matile S, Dubochet J, Sadoul R, Parton RG, Vilbois F, Gruenberg J (2004) Role of LBPA and Alix in multivesicular liposome formation and endosome organization. Science 303:531–534
Moore RM, Lundgren DW, Silver RJ, Moore JJ (2002) Lactosylceramide-induced apoptosis in primary amnion cells and amnion-derived WISH cells. J Soc Gynecol Investig 9:282–289
Mukhin DN, Chao FF, Kruth HS (1995) Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis. Arterioscler Thromb Vasc Biol 15:1607–1615
Muthing J, Maurer U, Neumann U, Kniep B, Weber-Schurholz S (1998) Glycosphingolipids of skeletal muscle: I. Subcellular distribution of neutral glycosphingolipids and gangliosides in rabbit skeletal muscle. Carbohydr Res 307:135–145
Natomi H, Sugano K, Iwamori M, Takaku F, Nagai Y (1988) Region-specific distribution of glycosphingolipids in the rabbit gastrointestinal tract: preferential enrichment of sulfoglycolipids in the mucosal regions exposed to acid. Biochim Biophys Acta 961:213–222
Nilsson O, Mansson JE, Hakansson G, Svennerholm L (1982) The occurrence of psychosine and other glycolipids in spleen and liver from the three major types of Gaucher’s disease. Biochim Biophys Acta 712:453–463
Parkin ET, Turner AJ, Hooper NM (2001) Differential effects of glycosphingolipids on the detergent-insolubility of the glycosylphosphatidylinositol-anchored membrane dipeptidase. Biochem J 358:209–216
Philippart M, Rosenstein B, Menkes JH (1965) Isolation and characterization of the main splenic glycolipids in the normal organ and in Gaucher’s disease: evidence for the site of metabolic block. J Neuropathol Exp Neurol 24:290–303
Philippart M, Martin L, Martin JJ, Menkes JH (1969) Niemann-Pick disease. Morphologic and biochemical studies in the visceral form with late central nervous system involvement (Crocker’s group C). Arch Neurol 20:227–238
Prokazova NV, Mukhin DN, Orekhov AN, Gladkaya EM, Vasilevskaya VV, Mikhailenko IA, Sadovskaya VL, Bushuev VN, Bergelson LD (1989) Neutral glycolipids of atherosclerotic plaques and unaffected human aorta tissue. Eur J Biochem 180:167–171
Puri V, Watanabe R, Dominguez M, Sun X, Wheatley CL, Marks DL, Pagano RE (1999) Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases. Nat Cell Biol 1:386–388
Rouser G, Kritchevsky G, Yamamoto A, Knudson AG, Simon G (1968) Accumulation of a glycerophospholipid in classical Niemann-Pick disease. Lipids 3:287–290
Saito M, Rosenberg A (1985) The fate of glucosylceramide (glucocerebroside) in genetically impaired (lysosomal beta-glucosidase deficient) Gaucher disease diploid human fibroblasts. J Biol Chem 260:2295–2300
Sandhoff K, Kolter T, Harzer K (2001) Sphingolipid activator proteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3371–3388
Seng PN, Debuch H, Witter B, Wiedemann HR (1971) Augmentation of bis(monoacylglycerin)phosphoric acid in sphingomyelinosis (M. Niemann-Pick?). Hoppe Seylers Z Physiol Chem 352:280–288
Simons K, Gruenberg J (2000) Jamming the endosomal system: lipid rafts and lysosomal storage diseases. Trends Cell Biol 10:459–462
Suomi WD, Agranoff BW (1965) Lipids of the spleen in Gaucher’s disease. J Lipid Res 58:211–219
Suzuki A, Kundu SK, Marcus DM (1980) An improved technique for separation of neutral glycosphingolipids by high-performance liquid chromatography. J Lipid Res 21:473–477
Svennerholm L, Vanier MT, Mansson JE (1980) Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. J Lipid Res 21:53–64
Symington FW, Murray WA, Bearman SI, Hakomori S (1987) Intracellular localization of lactosylceramide, the major human neutrophil glycosphingolipid. J Biol Chem 262:11356–11363
Tjiong HB, Seng PN, Debuch H, Wiedemann HR (1973) Brain lipids of a case of juvenile Niemann-Pick disease. J Neurochem 21:1475–1485
Van Hoof F (1973) GM1-gangliosidosis. In: Hers HG, Van Hoof F (eds) Lysosomes and storage diseases. Academic Press, New York, pp 305–322
Van Hoof F (1973) Mucopolysaccharidoses. In: Hers HG, Van Hoof F (eds) Lysosomes and storage diseases. Academic Press, New York, pp 218–262
van Meer G, Lisman Q (2002) Sphingolipid transport: rafts and translocators. J Biol Chem 277:25855–25858
Vanier MT (1983) Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. Biochim Biophys Acta 750:178–184
Vanier MT (1999) Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Neurochem Res 24:481–489
Walkley SU (2004) Secondary accumulation of gangliosides in lysosomal storage disorders. Semin Cell Dev Biol 15:433–444
Whitfield PD, Nelson P, Sharp PC, Bindloss CA, Dean C, Ravenscroft EM, Fong BA, Fietz MJ, Hopwood JJ, Meikle PJ (2002) Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: implications for the prediction of disease severity. Mol Genet Metab 75:46–55
Yeh LH, Kinsey AM, Chatterjee S, Alevriadou BR (2001) Lactosylceramide mediates shear-induced endothelial superoxide production and intercellular adhesion molecule-1 expression. J Vasc Res 38:551–559
Zervas M, Dobrenis K, Walkley SU (2001) Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J Neuropathol Exp Neurol 60:49–64
Zimmerman JW, Lindermuth J, Fish PA, Palace GP, Stevenson TT, DeMong DE (1998) A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J Biol Chem 273:22014–22020
Acknowledgements
The excellent technical assistance of Miss Jana Sovová is gratefully acknowledged. The study was supported by research project of the Ministry of Education of the Czech Republic (VZ 111100003) and by the Grant Agency of Charles University (GAUK 16/2002/c).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hůlková, H., Ledvinová, J., Asfaw, B. et al. Lactosylceramide in lysosomal storage disorders. A comparative immunohistochemical and biochemical study. Virchows Arch 447, 31–44 (2005). https://doi.org/10.1007/s00428-005-1246-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-005-1246-y